gene editing – Artifex.News https://artifexnews.net Stay Connected. Stay Informed. Thu, 22 Aug 2024 00:00:00 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.2 https://artifexnews.net/wp-content/uploads/2023/08/cropped-Artifex-Round-32x32.png gene editing – Artifex.News https://artifexnews.net 32 32 ICAR, Penn State team makes tool small enough to edit plant genomes https://artifexnews.net/article68549229-ece/ Thu, 22 Aug 2024 00:00:00 +0000 https://artifexnews.net/article68549229-ece/ Read More “ICAR, Penn State team makes tool small enough to edit plant genomes” »

]]>

Flour, chocolate, cocoa powder, eggs, and butter are all the ingredients to make a sweet treat you crave.

The only thing you need right now is a step-by-step recipe to help you turn the ingredients into a yummy brownie.

Too big for its britches

Nature also has the ingredients it needs to ‘make’ living organisms, using a genetic instruction manual called the genome. A small change in the genome’s composition can determine whether the living thing being made is a flower that exhibits two petal colours, a cat that has big or small ears or if the coriander leaves will taste like soap to some people.

With the help of the gene-editing tool CRISPR, scientists today can precisely edit genomes to introduce desirable genetic traits or remove undesirable ones.

CRISPR holds the potential to revolutionise agriculture in particular by allowing agricultural scientists to increase crop yields and improve resistance to disease and anomalous weather through gene-editing. However, there has been a critical obstacle: a commonly used form of the CRISPR system is too big for plant genomes.

This system uses one of two proteins, Cas9 or Cas12, to target specific parts of the DNA. But they are too bulky for plant cells to accommodate.

Smaller is better

A team of researchers led by Kutubuddin Molla from the ICAR-National Rice Research Institute in Cuttack and Mirza Baig from the Pennsylvania State University in the U.S. presented an alternative that could solve this major problem in plant genome editing in a recent paper in the journal Plant Biotechnology Journal.

They reported developing a plant genome editor consisting of a protein called ISDra2TnpB, derived from bacteria called Deinococcus radiodurans (famous for being able to survive extreme environmental conditions). ISDra2TnpB is less than half the size of Cas9 and Cas12.

V.S. Sresty Tavva, principal scientist at the Crop Improvement Program at the Tata Institute for Genetics and Society (TIGS), Bengaluru, who wasn’t involved in the study, expressed enthusiasm over its findings.

“Currently, [since] there are not many options available for plant genome editors, the improved TnpB certainly adds value. One should utilise the advantage of the size of TnpB in generating edited plants for various traits of interest,” he said.

TnpB’s editing chops

TnpB is a protein made up of around 400 amino acid units (different combinations of the 20 amino acids make up all proteins). It belongs to a family of transposable elements, or transposons. Sometimes called “jumping genes”, transposons are parts of a genome that can move from one location to another.

The genome consists of two strands of DNA bonded to each other. Each strand is made up of building blocks called nucleotides. In turn, each nucleotide has three pieces; two are common to all of them whereas the identity of the third one can be one of four options: adenine (A), thymine (T), cytosine (C) or guanine (G). The DNA’s ‘sequence’ refers to the order in which nucleotides containing these four compounds are arranged.

In the new system, TnpB hitches a ride on a piece of RNA that guides it to the target DNA sequence. Once there the TnpB binds with the sequence and eliminates it. The cell that houses this DNA repairs the cut by restoring the ‘correct’ sequence. Thus, the genome is modified to replace an undesirable sequence with a desirable one.

The researchers behind the new study exploited the genome editing abilities of a TnpB-based system to achieve a 33.58% editing efficiency in an average plant genome on targets that Cas9 or Cas12 couldn’t reach. They demonstrated that the genome editor was effective on both types of flowering plants—monocots (like rice, which have one seed leaf) and dicots (like Arabidopsis, a plant related to cabbage and mustard that has two seed leaves).

Codons and regulators

The team also built four versions of the TnpB-based editing tool and tested them on rice protoplasts — plant cells without the cell wall — to identify the best among them. In their initial experiments, the versions had a low editing efficiency.

To improve it, Dr. Molla et al. did two things. First, they used a process called codon optimisation. For example, cells in the body make the amino acid lysine by following an instruction in the genome represented by a sequence of three nucleotides. Such sequences of three are called codons.

The codon sequence that contains the recipe for lysine varies in different types of organisms. TnpB is a protein extracted from D. radiodurans, a prokaryotic bacteria, which has a different codon for lysine than do eukaryotes like plants. So the researchers edited the codon bias of TnpB to match that of rice protoplasts to improve the editing efficiency, Dr. Molla explained.

The second thing the researchers tweaked were the regulatory elements. When the TnpB and the specific RNA that guides it to the target DNA are transferred from a prokaryote to a eukaryote, researchers also need to include sequences called promoters and terminators that govern and regulate the expression of TnpB.

“We added promoters that are likely to enhance the expression of TnpB and lead to better editing,” Dr. Molla said.

A hi-res upgrade

The researchers finished with some finishing touches to the TnpB-based gene-editing system. They deactivated TnpB and fused it with another protein to create a ‘hybrid’ base editor.

When accompanied by the guide RNA, this editor could swap out a single nucleotide in the DNA sequence.

This wasn’t possible with the previous version, with active TnpB, because it tended only to delete DNA sequences and couldn’t swap one sequence for another.

The new base editor thus opened up exciting possibilities for crop innovation by facilitating the alteration of genes at the level of individual nucleotides.

A future of edited plants

The TnpB-based editors the researchers built can edit the plant genome using both base editing and transcription activation, two widely used techniques in plant synthetic biology.

Dr. Tavvahowever said most of the claims were based on data obtained from protoplasts and that the scenario might change when dealing with processes by which an organism absorbs external DNA and integrates it into its genome.

It also appeared that the efficiency of the base editing system fell short in dicot plants as indicated by the results (0.2-0.46% average editing efficiency) reported using Arabidopsis. “Regardless,” Dr. Tavva said, “the plant genome editing community should try this miniature editing system in crop species of their choice to improve various traits of interest.”

TIGS director Rakesh Mishra echoed him: “It is exciting to see a novel and effective genome editing tool being invented. While more development will be needed, alternatives like this are welcome news.”

The researchers have expressed hope this miniature genome editing tool will help remove anti-nutrient factors from food crops, reduce their susceptibility to pests, and help rice crops become shorter and less prone to damage during cyclones.

Sanjukta Mondal is a chemist-turned-science-writer with experience in writing popular science articles and scripts for STEM YouTube channels.



Source link

]]>
TB: gene editing could add new power to a 100-year-old vaccine https://artifexnews.net/article68472024-ece/ Wed, 14 Aug 2024 07:17:49 +0000 https://artifexnews.net/article68472024-ece/ Read More “TB: gene editing could add new power to a 100-year-old vaccine” »

]]>

Tuberculosis dates back more than 9,000 years. It is the most infectious bacterial disease and in 2022 10.6 million people fell ill with it.
| Photo Credit: Getty Images/iStockphoto

Tuberculosis dates back more than 9,000 years. It is the most infectious bacterial disease and in 2022 10.6 million people fell ill with it. Of these 23% occurred in Africa.

The only vaccine against tuberculosis, the Bacillus Calmette-Guérin (BCG) vaccine, is more than 100 years old and is primarily effective for infants and young children.

Researchers at the University of the Witwatersrand School of Pathology have made a significant breakthrough in vaccine development by gene-editing the BCG to make it more effective.

Mice vaccinated with the modified BCG vaccine were better able to limit tuberculosis growth in their lungs than mice that had received the original vaccine.

Microbiologist Bavesh Kana, one of the lead researchers, explains to Nadine Dreyer from The Conversation Africa the science behind this breakthrough and the potential it holds for other vaccines.

How do vaccines work?


Vaccines primarily work by mimicking dangerous infectious agents. You want your immune system to recognise the vaccine as an “invader” and then mount an immune response to it. But you don’t want the invasive agent to make you sick.

To understand how vaccines work, it helps to look at how the immune system works, because vaccines harness the natural activity of your immune system.

The immune system: There are about 100 trillion bacteria and viruses in the gastrointestinal tract.

The proteins and sugars on the surface of bacteria, viruses or other disease-causing pathogens have different shapes to any of the ones in the human body. These markers are pathogen-associated molecular patterns, commonly known as PAMPs. Think of the spikes on coronavirus.

So, your immune system quickly recognises the invaders. And the body fights back with a complex chain of events involving many different types of white blood cells working together. See video below on how the immune system works.

One type of white blood cell is able to make antibodies to fight the invaders. These antibodies can stick to the proteins or sugars on the bacteria’s surface, and this kills the bacteria or disables them. They have to be exactly the right shape, a bit like a key fitting a door. These white blood cells are known as B-cells.

Producing antibodies of the right shape can take several days. By this time there could be billions of disease-causing bacteria in your body.

Once the right cells are activated, they quickly divide and turn into a production line, making masses of antibodies that stick to the invading agents and disable them.

Eventually, your body gets rid of all the invaders and you recover.

Antibodies remain in the blood, and some white blood cells may also become memory cells for specific bacteria in case they invade the body again.

So with this stored arsenal of tools the immune system will respond quickly to future invasions.

Vaccines: Vaccines work in the same way as the immune system. They contain weakened or dead bacteria or viruses or even just a few proteins or sugars from the surface. This is enough to convince the immune system that a real invader has entered the body.

So the same process takes place as when real bacteria or viruses invade our bodies, except you don’t get ill afterwards. Vaccines are engineered to look like pathogens but are made in such a way that they do not make you sick.

When you do encounter the real agent, you have immunological memory, because your body has been exposed to something that looks very similar.

And that immunological memory allows you to withstand the infection or even prevent establishment of full infection, or to manage the infection without getting too sick.

How did you go about modifying the TB vaccine?


TB vaccines are very challenging to develop. The bacterium that causes the disease is complex. It is also proficient at evading the human immune system, which is why there is only one vaccine that has been developed against the disease in 100 years.

Our laboratory does a lot of TB research and for a long time we’ve been interested in the cell wall of these bacteria. We noticed that the cell wall has a small chemical decoration on the surface and that chemical decoration allows the bacteria to hide an important marker (PAMP), called the NOD-1 ligand, from the immune system.

Both the tuberculosis and the live bacteria used in the BCG vaccine are able to hide the NOD-1 ligand from the immune system, making it harder for the body to detect them.

We thought that modifying the BCG bacterium so it cannot hide this NOD-1 ligand might lead to a new, more effective vaccine.

To investigate this possibility we turned to CRISPR, a gene editing technology that allows scientists to modify DNA.

We used CRISPR to develop a modified version of the BCG bacterium which is unable to hide its NOD-1 ligand.

Mice vaccinated with the modified BCG vaccine were better able to limit tuberculosis growth in their lungs than mice that had received the original vaccine.

Further studies will be needed to modify the vaccine for use in humans.

What happens now?


Our findings offer a new candidate vaccine in the fight against tuberculosis.

With some novel vaccine candidates in the pipeline, we can finally begin to address this devastating illness adequately.

This work is very exciting because it demonstrates that gene editing is a powerful way to develop vaccines and may help develop more effective vaccines for other diseases in the future.

Bavesh Kana is the Head of the Centre of Excellence for Biomedical TB Research at the University of the Witwatersrand. This article is republished from The Conversation.



Source link

]]>
New Zealand to loosen gene editing regulation, make commercialisation easier https://artifexnews.net/article68523684-ece/ Wed, 14 Aug 2024 06:53:33 +0000 https://artifexnews.net/article68523684-ece/ Read More “New Zealand to loosen gene editing regulation, make commercialisation easier” »

]]>

The New Zealand government said that it would introduce new legislation to make it easier for companies and researchers to develop and commercialise products using gene technologies.
| Photo Credit: Getty Images

The New Zealand government said on Tuesday that it would introduce new legislation to make it easier for companies and researchers to develop and commercialise products using gene technologies such as gene editing.

Science, Innovation and Technology Minister Judith Collins said in a statement that rules and time-consuming processes have made research outside the lab almost impossible.

“These changes will bring New Zealand up to global best practice and ensure we can capitalise on the benefits,” she said.

Current regulations mean that genetically modified organisms (GMOs) cannot be released out of containment without going through a complex and vigorous process and it is difficult to meet the set standard. Furthermore, gene editing is considered the same as genetic modification even when it doesn’t involve the introduction of foreign DNA.

Under the new law, low-risk gene editing techniques that produce changes indistinguishable from conventional breeding will be exempted from regulation, local authorities will no longer be able to prevent the use of GMOs in their regions and there will be a new regulator of the industry.

“This is a major milestone in modernising gene technology laws to enable us to improve health outcomes, adapt to climate change, deliver massive economic gains and improve the lives of New Zealanders,” Collins said.

The government hopes to have the legislation passed and the regulator in operation by the end of 2025.



Source link

]]>
Gene editing offers chickens some protection against bird flu https://artifexnews.net/article67411374-ece/ Thu, 12 Oct 2023 10:02:56 +0000 https://artifexnews.net/article67411374-ece/ Read More “Gene editing offers chickens some protection against bird flu” »

]]>

A turkey stands in a barn, Aug. 10, 2015, on a turkey farm near Manson, Iowa. The U.S. Department of Agriculture reported that avian influenza (bird flu), which is deadly to commercial poultry, was confirmed in a flock of 47,300 turkeys in Jerauld County of South Dakota last Wednesday, Oct. 4, 2023, and at a farm with 141,800 birds in Sanpete County of Utah last Friday, Oct. 6.
| Photo Credit: AP

Scientists in Britain have found they can partially protect chickens from bird flu infections by editing their genes, signalling a new potential strategy to reduce the spread of the deadly virus.

Highly pathogenic avian influenza, known as bird flu, has spread to new corners of the globe since 2022, wiping out millions of poultry birds and sending egg and turkey prices soaring.

Experts warn that mutations could potentially threaten a human pandemic, though the current strain has not caused significant disease in people.

Researchers said they used the gene-editing tool CRISPR to make specific changes to a gene called ANP32 that is essential to support flu viruses inside chickens’ cells. CRISPR is a type of molecular “scissor” technology that scientists can use to edit DNA.

Also Read | Mammalian spread of H5N1 and its pandemic potential 

Flu viruses hijack proteins like ANP32 inside cells to help themselves replicate, and the edits in chickens were designed to stop the growth of bird flu.

Upticks in cases tend to occur during the spring and autumn migration of wild birds that transmit the virus, and the U.S. last week reported its first case in a commercial flock since April.

Experiments showed that almost all of the gene-edited chickens showed resistance to lower doses of a less lethal form of bird flu than the H5N1 strain that has circulated the globe recently, said Wendy Barclay, a flu expert and professor at the Imperial College of London.

When birds were exposed to much higher levels of the virus, though, about half of the gene-edited chickens had breakthrough infections, she said.

Also Read | Most avian flu outbreaks in India reported from post-monsoon to pre-summer season: study

“We can move toward making chickens resistant to the virus but we’re not there yet,” Barclay said. “We would need more edits – more robust edits – to really shut down the virus replication.”

The findings were published in Nature Communications on Tuesday.

Researchers now think that making three specific genetic changes to chickens’ cells will better protect birds. However, they have not bred chickens with three edits yet, said Helen Sang, who previously studied genetically modifying chickens against bird flu at the University of Edinburgh.

Sang said scientists found that genetic modification would not work well enough.

Unlike genetic modification, which introduces foreign genes, gene editing alters existing genes. The technology is considered to be less controversial than genetic modification and is more lightly regulated in some countries.

“The way forwards here is not to rely on single edits but to use a combination of them,” Barclay said.

France this month became the first country in the European Union to vaccinate poultry against the virus.

However, that strategy led the U.S. to impose trade restrictions on French poultry imports, citing a risk of introducing the virus into the country because vaccinated birds may not show signs of infection.



Source link

]]>